T. Rowe Price Associates
VITL icon

T. Rowe Price Associates’s Vital Farms VITL Stock Holding History

T. Rowe Price Associates’s Portfolio VITL Stock Details VITL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$788K Buy
67,673
+5,645
+9% +$62.9K ﹤0.01% 2429
2026
Q1 		$876K Sell
62,028
-614,426
-91% -$14.5M ﹤0.01% 2223
2025
Q4 		$21.6M Buy
676,454
+5,519
+0.8% +$194K ﹤0.01% 1050
2025
Q3 		$27.6M Buy
670,935
+5,405
+0.8% +$235K ﹤0.01% 977
2025
Q2 		$25.6M Buy
665,530
+3,472
+0.5% +$117K ﹤0.01% 898
2025
Q1 		$20.2M Sell
662,058
-116
-0% -$4.17K ﹤0.01% 952
2024
Q4 		$25M Buy
662,174
+239,552
+57% +$8.52M ﹤0.01% 941
2024
Q3 		$14.8M Buy
422,622
+409,762
+3,186% +$14.5M ﹤0.01% 1060
2024
Q2 		$602K Sell
12,860
-13,650
-51% -$471K ﹤0.01% 2114
2024
Q1 		$617K Buy
26,510
+1,402
+6% +$24.5K ﹤0.01% 2129
2023
Q4 		$394K Buy
25,108
+919
+4% +$11.6K ﹤0.01% 2275
2023
Q3 		$281K Buy
24,189
+714
+3% +$8.22K ﹤0.01% 2357
2023
Q2 		$282K Buy
23,475
+133
+0.6% +$1.86K ﹤0.01% 2390
2023
Q1 		$358K Buy
23,342
+649
+3% +$10.3K ﹤0.01% 2260
2022
Q4 		$339K Sell
22,693
-5,496
-19% -$75.8K ﹤0.01% 2324
2022
Q3 		$338K Buy
28,189
+11,482
+69% +$137K ﹤0.01% 2323
2022
Q2 		$146K Buy
16,707
+4,339
+35% +$46.2K ﹤0.01% 2675
2022
Q1 		$153K Buy
12,368
+500
+4% +$7.51K ﹤0.01% 2768
2021
Q4 		$214K Buy
+11,868
New +$209K ﹤0.01% 2730
2020
Q4 		– Sell
-5,035
Closed -$204K – 2720
2020
Q3 		$204K Buy
+5,035
New +$190K ﹤0.01% 2414

Other funds holding VITL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

T. Rowe Price Associates's VITL Position: Q2 2026 in Review

T. Rowe Price Associates increased its Vital Farms (VITL) stake by 9.1% in Q2 2026, buying an estimated $62.9K and bringing the position to 67,673 shares worth $788K. The position accounts for ﹤0.01% of the portfolio, ranked #2429.

T. Rowe Price Associates first reported a position in VITL in Q3 2020 and has held it in 20 quarters since. The position peaked at $27.6M in Q3 2025. 226 funds tracked by Wall St. Rank hold VITL as of Q2 2026.

  • T. Rowe Price Associates held 67,673 shares of Vital Farms worth $788K as of Q2 2026.
  • T. Rowe Price Associates bought 5,645 Vital Farms shares in Q2 2026, an estimated $62.9K.
  • Vital Farms made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2429 holding.
  • T. Rowe Price Associates first reported a position in Vital Farms in Q3 2020 and has held it in 20 quarters since.
  • T. Rowe Price Associates's Vital Farms position peaked at $27.6M in Q3 2025.
  • 226 funds tracked by Wall St. Rank held Vital Farms as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.